FDA.reportPublic FDA data

POTASSIUM CHLORIDE

Substance profile for UNII 660YQ98I10, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for POTASSIUM CHLORIDE
Structure render from PubChem CID 4873

Substance Identity#

UNII
660YQ98I10
Preferred term
POTASSIUM CHLORIDE
Registry number
7447-40-7
EC number
231-211-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Cl.K
Chemical structure for POTASSIUM CHLORIDE
Structure render from PubChem CID 4873

Chemical And Database Identifiers#

InChIKey
WCUXLLCKKVVCTQ-UHFFFAOYSA-M
SMILES
[Cl-].[K+]
RxCUI
8591
PubChem
4873
NCIt
C47679
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound4873pubchem.ncbi.nlm.nih.gov/compound/4873
PubChem InChIKey SearchWCUXLLCKKVVCTQ-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=WCUXLLCKKVVCTQ-UHFFFAOYSA-M
RxNorm8591mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=8591
NCI ThesaurusC47679ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47679
FDA Substance Registration System660YQ98I10precision.fda.gov/uniisearch/srs/unii/660YQ98I10
European Community number231-211-8commonchemistry.cas.org/results?q=231-211-8

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTffe98484-20b7-4578-b9cc-0707f8e3d2b12
INACTIVE INGREDIENT1af7e6c4-b25f-4edc-a625-a3e2ee0c9f512
INACTIVE INGREDIENT9ca6cfb5-e942-4907-be8e-a24e8895d6cf2
INACTIVE INGREDIENTa5b8f7d4-8d97-4d15-8477-a5d0eadb8ac72
INACTIVE INGREDIENT708731af-9420-4ef4-ac83-80b95938f8c92
INACTIVE INGREDIENT64b5b884-c54c-462d-99a9-b155ef61094c3
INACTIVE INGREDIENT898c289f-6178-4824-9438-07fbb9bd8e0e2
INACTIVE INGREDIENT748f6c30-a2ac-46be-9a31-5a37ecfa79262
ACTIVE INGREDIENTKLOR-CON ® M Potassium Chloride Extended-release Tablets, USP 10 mEq, 15 mEq, and 20 mEq MICRO-DISPERSIBLE ® TECHNOLOGY6
ACTIVE INGREDIENTfc36eaa5-499d-4a96-a144-cffae64878a41
ACTIVE INGREDIENTAllergies:Pacific U.S.1
ACTIVE INGREDIENTAllergyEase Great Lakes2
ACTIVE INGREDIENTDRUGS FACTS1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use AFLURIA safely and effectively. See full prescribing information for AFLURIA. AFLURIA, Influenza Vaccine Suspension for Intramuscular Injection 2015-2016 Formula Initial U.S. Approval: 20075
INACTIVE INGREDIENTaacd7051-8f9c-4be4-98a6-62a314f7b71b1
ACTIVE INGREDIENTPotassium Chloride Extended-Release Capsules, USP 8 mEq (600 mg) and 10 mEq (750 mg) Rx Only6
ACTIVE INGREDIENTVETIVEX™ 111
ACTIVE INGREDIENTPOTASSIUM CHLORIDE EXTENDED - RELEASE TABLETS, USP1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use PRISMASOL and PHOXILLUM safely and effectively. See full prescribing information for PRISMASOL and PHOXILLUM. PRISMASOL renal replacement solution PRISMASOL Initial U.S. Approval: 2006 PHOXILLUM renal replacement solution PHOXILLUM Initial U.S Approval: 20152
ACTIVE INGREDIENTCMPK SOLUTION1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules Omeprazole delayed-release capsules, USP, for oral administration Initial U.S. Approval: 198912
INACTIVE INGREDIENT344a308a-5384-45de-8649-25461a65ccaf5
INACTIVE INGREDIENTedcb54cf-33c4-46d8-adc6-c13e7145b1781
INACTIVE INGREDIENTOxytocin 20 USP Units Added to Lactated Ringer's 1,000 mL Bag5
ACTIVE INGREDIENTPotassium Chloride Oral Solution USP (20% Solution)2
ACTIVE INGREDIENTSkin Irritation and Itch Response1
INACTIVE INGREDIENTd1b30723-e2b1-4772-a11e-57ba9acc93432
INACTIVE INGREDIENTa9bdb9b3-51fb-453d-9961-3babdf4b65451
INACTIVE INGREDIENTOxytocin 30 USP Units Added to Lactated Ringer's 500 mL Bag5
INACTIVE INGREDIENT0b1b3484-be16-45ba-a0b0-deb59f31fd849
INACTIVE INGREDIENTf0965985-2ca2-4cb7-b999-e726c642b6441
ACTIVE INGREDIENTMilk Fever2
ACTIVE INGREDIENTMilk Fever1
INACTIVE INGREDIENTLumininizing moisture tint sunscreen broard spectrum SPF 20 "Blush"1
INACTIVE INGREDIENTOxytocin 20 USP Units Added to 5% Dextrose/Lactated Ringer's 1,000 mL Bag3
INACTIVE INGREDIENTOxytocin 30 USP Units Added to 5% Dextrose/Lactated Ringer's 500 mL Bag2
ACTIVE INGREDIENTPotassium Chloride1
ACTIVE INGREDIENTDRUG FACTS:1
INACTIVE INGREDIENTPond's Luminous Finish BB Cream Light SPF 152
INACTIVE INGREDIENTPond's Luminous Finish BB Cream Medium SPF 152
INACTIVE INGREDIENTThese highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 20091
ACTIVE INGREDIENTAllergies Southern US1
INACTIVE INGREDIENTmatte moisture tint sunscreen broard spectrum SPF 15 "Nude"1
INACTIVE INGREDIENTmatte moisture tint sunscreen broard spectrum SPF 15 "Chamomile"1
INACTIVE INGREDIENTmatte moisture tint sunscreen broard spectrum SPF 15 "Porcelain"1
INACTIVE INGREDIENTmatte moisture tint sunscreen broard spectrum SPF 15 "Hazel"1
INACTIVE INGREDIENTac66f038-d617-4f5c-8800-13ef6f6353fc1
ACTIVE INGREDIENTPOTASSIUM CHLORIDE EXTENDED - RELEASE TABLETS, USP2
ACTIVE INGREDIENTAllergies™ Northeast U.S.1
ACTIVE INGREDIENTAllergies™ Rocky MTNS. U.S.1
ACTIVE INGREDIENTDrug Facts4
INACTIVE INGREDIENTBuPROPion Hydrochloride Tablets, USP3
INACTIVE INGREDIENTBuPROPion Hydrochloride Tablets, USP3
ACTIVE INGREDIENTKLOR-CON ® M (Potassium Chloride Extended-release Tablets, USP) 10 mEq, 15 mEq and 20 mEq MICRO-DISPERSIBLE TECHNOLOGY ® Rx only1
ACTIVE INGREDIENTPOTASSIUM CHLORIDE EXTENDED RELEASE TABLETS USP 20 mEq K Rx Only 1737142
ACTIVE INGREDIENTK-TAB® (potassium chloride extended-release tablets, USP)2
ACTIVE INGREDIENTChildren's Ear Relief ™1
ACTIVE INGREDIENTCMPK23
ACTIVE INGREDIENTDRUGS FACTS1
ACTIVE INGREDIENTDRUGS FACTS1
INACTIVE INGREDIENTe043f9fe-8cbd-44f7-b8c1-fd8c5e4478f31
INACTIVE INGREDIENT7307cea8-7f86-4213-9d5f-9e210e9714bb2
ACTIVE INGREDIENTPotassium Chloride Extended-release Tablets, USP Microencapsulated3
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTWart Freee™2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE TABLETS, USP safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE TABLETS, USP. Bupropion Hydrochloride Tablets, USP for oral use Initial U.S. Approval: 19852
ACTIVE INGREDIENTPotassium Chloride Extended-release Tablets, USP 8 mEq and 10 mEq1
INACTIVE INGREDIENTStila Sheer color tinted moisturizer broad spectrum SPF 20 (All Shades)1
INACTIVE INGREDIENTStila illuminating tinted moisturizer broad spectrum SPF 20 (All Shades)1
ACTIVE INGREDIENTDandRUFF Relief1
ACTIVE INGREDIENTMidwest Regional Allergies™1
INACTIVE INGREDIENTcebb4380-793e-4238-8f18-ddaa9c5fbc691
ACTIVE INGREDIENTPotassium Chloride Oral Solution, USP1
ACTIVE INGREDIENTRegional Allergies Plains U.S.™1
ACTIVE INGREDIENTPetAlive AmazaPet2
ACTIVE INGREDIENTKLOR-CON ® M (Potassium Chloride Extended-release Tablets, USP)15
ACTIVE INGREDIENTAllergyEase Pacific1
ACTIVE INGREDIENTAllergyEase Plains1
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTAllergyEase Northeastern1
ACTIVE INGREDIENTPetAlive LiverAid6
INACTIVE INGREDIENTe4edc41c-cbb0-427e-a4fe-573c1ee188993
INACTIVE INGREDIENTaf3bba43-b05e-416d-a34a-bf1029ab13f72
INACTIVE INGREDIENTa69e8c58-791b-4923-9810-a406c4dce42e2
INACTIVE INGREDIENT21c6299a-536f-461f-9d58-f0f67ff691882
ACTIVE INGREDIENTMucus-Clear1
ACTIVE INGREDIENTPotassium Chloride ER Caps6
INACTIVE INGREDIENTThese highlights do not include all the information needed to use ALPHAGAN ® P safely and effectively. See full prescribing information for ALPHAGAN ® P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% Initial U.S. Approval: 19964
ACTIVE INGREDIENTPOTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP, 10 mEq3
INACTIVE INGREDIENTCyclopentolate Hydrochloride Ophthalmic Solution USP, 1% (Sterile)2
ACTIVE INGREDIENTe773897c-d073-4f7b-af3b-067086cf942d1
ACTIVE INGREDIENTSKIN DR4
INACTIVE INGREDIENTb9685e2f-4009-45c8-ad09-03195dca879f3
ACTIVE INGREDIENTCoughEx Sprinkles1
INACTIVE INGREDIENTMagnesium Sulfate 20 g Added to Lactated Ringer's 500 mL Bag2
INACTIVE INGREDIENTREFRESH TEARS ®2
ACTIVE INGREDIENTPetAlive AmazaPet2
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTDrug Facts2
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENT6e9edbfc-1950-4893-9d38-e82b119ddb9a2
ACTIVE INGREDIENTPOTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS, USP6
ACTIVE INGREDIENTELLIOTTS B ® SOLUTION (buffered intrathecal electrolyte/dextrose injection) Rx Only6
INACTIVE INGREDIENTDrug Facts2
INACTIVE INGREDIENTMINERALIZE MOISTURE SPF 15 FOUNDATION1
ACTIVE INGREDIENTPotassium Chloride Extended-Release Capsules, USP 8 mEq (600 mg) and 10 mEq (750 mg) Rx Only P10009-1 08/113
INACTIVE INGREDIENTDrug Facts2
ACTIVE INGREDIENTLymph Detox1
ACTIVE INGREDIENTAllergyCare1
ACTIVE INGREDIENTPotassium Chloride Extended-release Tablets, USP Microencapsulated1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN. JALYN (dutasteride and tamsulosin hydrochloride) Capsules Initial U.S. Approval: 20101
ACTIVE INGREDIENTChildren's Earache Relief1
INACTIVE INGREDIENTmally Face Defender - Medium Foundation Broad Spectrum SPF 151
INACTIVE INGREDIENTThese highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
INACTIVE INGREDIENTDrug Facts1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 660YQ98I10 page 1 of 1 · 18 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POTASSIUM CHLORIDE660YQ98I107447407INJECTIONINFILTRATION0.3 mg
POTASSIUM CHLORIDE660YQ98I107447407INJECTIONINTRAMUSCULAR0.4 mg
POTASSIUM CHLORIDE660YQ98I107447407SOLUTIONINTRAOCULAR38 mg
POTASSIUM CHLORIDE660YQ98I107447407INJECTION, SOLUTIONINTRATHECAL1 mg
POTASSIUM CHLORIDE660YQ98I107447407INJECTIONINTRAVENOUS1 mg
POTASSIUM CHLORIDE660YQ98I107447407INJECTION, SOLUTIONINTRAVENOUS330 mg
POTASSIUM CHLORIDE660YQ98I107447407INJECTION, SUSPENSIONINTRAVITREAL0.08 %w/v
POTASSIUM CHLORIDE660YQ98I107447407SOLUTIONIRRIGATION0.04 %w/v
POTASSIUM CHLORIDE660YQ98I107447407POWDERNASALNA
POTASSIUM CHLORIDE660YQ98I107447407SOLUTIONOPHTHALMIC0.22 %w/v
POTASSIUM CHLORIDE660YQ98I107447407SOLUTION/ DROPSOPHTHALMIC0.14 %w/v
POTASSIUM CHLORIDE660YQ98I107447407SUSPENSIONOPHTHALMIC0.03 %w/w
POTASSIUM CHLORIDE660YQ98I107447407CAPSULEORAL62 mg
POTASSIUM CHLORIDE660YQ98I107447407CAPSULE, DELAYED RELEASEORAL2 mg
POTASSIUM CHLORIDE660YQ98I107447407SUSPENSIONORALNA
POTASSIUM CHLORIDE660YQ98I107447407TABLETORAL231 mg
POTASSIUM CHLORIDE660YQ98I107447407POWDERRESPIRATORY (INHALATION)0.18 mg
POTASSIUM CHLORIDE660YQ98I107447407SOAPTOPICALNA